We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sovereign Warned After Eliminating GMP Requirement, Said OGD Didn’t Need It
Sovereign Warned After Eliminating GMP Requirement, Said OGD Didn’t Need It
February 12, 2013
Sovereign Pharmaceuticals received an FDA warning letter for failing to test in-process blend samples to ensure uniformity, homogeneity and adequacy of mixing for its acetaminophen and hydrocodone bitartrate tablets.